drugset / Trial / NCT00407212
A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will investigate the effect of TCH346 compared to placebo in delaying the need for symptomatic treatment with dopaminergic agents
Timeline
- Start
- 2002-01
- Primary completion
- 2003-11
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omigapil | Small molecule | 1 mg | — |
| Subject | Omigapil | Small molecule | 5 mg | — |
| Subject | Omigapil | Small molecule | 20 mg | — |